×
About 80,270 results

ALLMedicine™ Ovarian Cancer Center

Research & Reviews  37,315 results

Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer.
https://doi.org/10.1080/1354750X.2021.1891291
Biomarkers : Biochemical Indicators of Exposure, Response... Helwa R, Gansmo LB et. al.

Mar 1st, 2021 - While large GWAS analyses have not found convincing associations between MDM2 promoter SNP55 and gynaecological cancers, SNP55 is in linkage disequilibrium with two other functional SNPs in the same promoter, likely to obscure associations between...

Gene Sequencing for Pathogenic Variants Among Adults With Breast and Ovarian Cancer in ...
https://doi.org/10.1001/jamanetworkopen.2021.0307
JAMA Network Open; George SHL, Donenberg T et. al.

Mar 1st, 2021 - Rates of breast and ovarian cancer are high in the Caribbean; however, to date, few published data quantify the prevalence of inherited cancer in the Caribbean population. To determine whether deleterious variants in genes that characterize the he...

Postoperative mobilisation as an indicator for the quality of surgical nursing care.
https://doi.org/10.12968/bjon.2021.30.4.S4
British Journal of Nursing (Mark Allen Publishing); Jakobsen DH, Høgdall C et. al.

Mar 1st, 2021 - Postoperative mobilisation is an important part of fundamental care. Increased mobilisation has positive effect on recovery, but immobilisation is still a challenge in postoperative care. To report how the establishment of a national nursing datab...

Long non-coding RNA SNHG1 stimulates ovarian cancer progression by modulating expressio...
https://doi.org/10.1002/1878-0261.12932
Molecular Oncology; Wu Y, Zhu B et. al.

Feb 28th, 2021 - Ovarian cancer (OC) is highly prevalent and associated with high mortality rates due to metastasis and relapse. In this study, we assessed the role of long non-coding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) in OC to gain further insig...

see more →

Guidelines  225 results

ESMO recommendations on predictive biomarker testing for homologous recombination defic...
https://doi.org/10.1016/j.annonc.2020.08.2102
Annals of Oncology : Official Journal of the European Soc... Miller RE, Leary A et. al.

Oct 2nd, 2020 - Homologous recombination repair deficiency (HRD) is a frequent feature of high-grade serous ovarian, fallopian tube and peritoneal carcinoma (HGSC) and is associated with sensitivity to PARP inhibitor (PARPi) therapy. HRD testing provides an oppor...

Olaparib shows 1-year survival benefit in recurrent ovarian cancer, BRCA mutations
https://www.healio.com/news/hematology-oncology/20200707/olaparib-shows-1year-survival-benefit-in-recurrent-ovarian-cancer-brca-mutations

Jul 6th, 2020 - Overall survival results from SOLO-2 showed patients with recurrent ovarian cancer and germline BRCA mutations added a year of life when treated with olaparib only, Ursula A. Matulonis, MD, of Dana Farber Cancer Institute, told Healio.

Patient survival greatly impacted by selection for ovarian cancer relapse surgery
https://www.healio.com/news/hematology-oncology/20200707/patient-survival-greatly-impacted-by-selection-for-ovarian-cancer-relapse-surgery

Jul 6th, 2020 - Studies presented during the ASCO2020 Virtual Scientific Program showed the benefit of validated selection tools in pursuing surgical measures for ovarian cancer relapse, Ursula A. Matulonis, MD, of Dana Farber Cancer Institute, told Healio.

Expert Perspective on ASCO20 Gynecologic Oncology Research
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200233/full/

Jul 2nd, 2020 - DESKTOP III (Abstract 6000) is a prospective, multicenter, randomized phase III study of > 400 patients with platinum-sensitive, recurrent ovarian cancer that demonstrated a clinically meaningful 7.7 month improvement in median overall survival wi...

Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: Internatio...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294297
Gynecologic Oncology; Elledge CR, Beriwal S et. al.

Jun 21st, 2020 - To develop expert consensus recommendations regarding radiation therapy for gynecologic malignancies during the COVID-19 pandemic. An international committee of ten experts in gynecologic radiation oncology convened to provide consensus recommenda...

see more →

Drugs  133 results see all →

Clinicaltrials.gov  40,105 results

Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer.
https://doi.org/10.1080/1354750X.2021.1891291
Biomarkers : Biochemical Indicators of Exposure, Response... Helwa R, Gansmo LB et. al.

Mar 1st, 2021 - While large GWAS analyses have not found convincing associations between MDM2 promoter SNP55 and gynaecological cancers, SNP55 is in linkage disequilibrium with two other functional SNPs in the same promoter, likely to obscure associations between...

Gene Sequencing for Pathogenic Variants Among Adults With Breast and Ovarian Cancer in ...
https://doi.org/10.1001/jamanetworkopen.2021.0307
JAMA Network Open; George SHL, Donenberg T et. al.

Mar 1st, 2021 - Rates of breast and ovarian cancer are high in the Caribbean; however, to date, few published data quantify the prevalence of inherited cancer in the Caribbean population. To determine whether deleterious variants in genes that characterize the he...

Postoperative mobilisation as an indicator for the quality of surgical nursing care.
https://doi.org/10.12968/bjon.2021.30.4.S4
British Journal of Nursing (Mark Allen Publishing); Jakobsen DH, Høgdall C et. al.

Mar 1st, 2021 - Postoperative mobilisation is an important part of fundamental care. Increased mobilisation has positive effect on recovery, but immobilisation is still a challenge in postoperative care. To report how the establishment of a national nursing datab...

Long non-coding RNA SNHG1 stimulates ovarian cancer progression by modulating expressio...
https://doi.org/10.1002/1878-0261.12932
Molecular Oncology; Wu Y, Zhu B et. al.

Feb 28th, 2021 - Ovarian cancer (OC) is highly prevalent and associated with high mortality rates due to metastasis and relapse. In this study, we assessed the role of long non-coding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) in OC to gain further insig...

see more →

News  2,425 results

Study: Pap Test/Cervical Swab Samples Can Reveal Ovarian Cancer Biomarkers
https://www.medscape.com/viewarticle/946396

Feb 23rd, 2021 - Residual fixatives from liquid-based Pap tests and cervical swabs contain tumor-specific biomarkers for ovarian cancer, according to an analysis of proteins found in matched biospecimens from a woman with high grade serous ovarian cancer. The find...

London Team Identifies New Prognostic Biomarker for Ovarian Cancer
https://www.medscape.com/viewarticle/924968

Jan 31st, 2021 - A team of surgeons from Imperial College London have discovered a new biomarker for poor prognosis in patients with advanced high-grade serous ovarian cancer (HGSOC). In research published in the  British Journal of Cancer,  the team identified an...

Nulliparity, Not ART, Likely Raises Risk of Ovarian Cancer
https://www.medscape.com/viewarticle/944346

Jan 18th, 2021 - Women who receive ovarian stimulation for assisted reproductive technology (ART) procedures don't have an increased risk of developing ovarian cancer when compared to subfertile women who don't undergo ART, according to a new study. The results su...

NICE Approves 'Game-changing' Ovarian Cancer Drug
https://www.medscape.com/viewarticle/944178

Jan 14th, 2021 - Niraparib (Zejula, GlaxoSmithKline) has been approved by the National Institute for Health and Care Excellence (NICE) for England's Cancer Drugs Fund (CDF) for some women with advanced ovarian cancer. The decision means the drug should also be ava...

Radiotherapy for Rectal Cancer Linked to Risk for Later Malignant Gynecological Neoplasms
https://www.medscape.com/viewarticle/943852

Jan 10th, 2021 - (Reuters Health) - Women who receive radiotherapy for rectal cancer may be at an increased risk of uterine and ovarian cancer, a new study suggests. In an analysis of information from the SEER database on more than 20,000 female patients diagnosed...

see more →

Patient Education  67 results see all →